Exclusive

Publication

Byline

Location

US Patent Issued to Juno Therapeutics on Aug. 11 for "Process for producing donor-batched cells expressing a recombinant receptor" (Washington Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,733, issued on Aug. 11, was assigned to Juno Therapeutics Inc. (Seattle). "Process for producing donor-batched cells expressing a recombina... Read More


US Patent Issued to Juno Therapeutics on Aug. 11 for "Method of assessing activity of recombinant antigen receptors" (Washington Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,734, issued on Aug. 11, was assigned to Juno Therapeutics Inc. (Seattle). "Method of assessing activity of recombinant antigen receptors" w... Read More


US Patent Issued to Seattle Children's Hospital on Aug. 11 for "Methods and compositions for engineering CD4-deficient CAR T cells and anti-CD4 CAR T cells and uses thereof" (Washington Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,735, issued on Aug. 11, was assigned to Seattle Children's Hospital (Seattle). "Methods and compositions for engineering CD4-deficient CAR ... Read More


US Patent Issued to BEIJING ZEQIN BIOMEDICAL on Aug. 11 for "Fusion peptide for treating autoimmune disease" (Chinese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,736, issued on Aug. 11, was assigned to BEIJING ZEQIN BIOMEDICAL Co. LTD (Beijing). "Fusion peptide for treating autoimmune disease" was in... Read More


US Patent Issued to Sartorius Lab Instruments on Aug. 11 for "Recombinant proteins based on fibrinogen" (German Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,737, issued on Aug. 11, was assigned to Sartorius Lab Instruments GmbH & Co. KG (Gottingen, Germany). "Recombinant proteins based on fibrin... Read More


US Patent Issued to Chugai Seiyaku on Aug. 11 for "Antibody constant region variant" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,738, issued on Aug. 11, was assigned to Chugai Seiyaku K.K. (Tokyo). "Antibody constant region variant" was invented by Tomoyuki Igawa (Shi... Read More


US Patent Issued to VANDERBILT UNIVERSITY on Aug. 11 for "Human antibodies to rift valley fever virus" (Tennessee Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,739, issued on Aug. 11, was assigned to VANDERBILT UNIVERSITY (Nashville, Tenn.). "Human antibodies to rift valley fever virus" was invente... Read More


US Patent Issued to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION on Aug. 11 for "GKN1 (gastrokine 1) specific antibody, and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,740, issued on Aug. 11, was assigned to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seoul, South Korea). "GK... Read More


US Patent Issued to AVEO Pharmaceuticals on Aug. 11 for "Treatment of congestive heart failure and other cardiac dysfunction using a GDF15 modulator" (Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,741, issued on Aug. 11, was assigned to AVEO Pharmaceuticals Inc. (Boston). "Treatment of congestive heart failure and other cardiac dysfun... Read More


US Patent Issued on Aug. 11 for "Bifunctional antagonists of activin and tumor necrosis factor alpha and uses thereof" (California Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,703,742, issued on Aug. 11. "Bifunctional antagonists of activin and tumor necrosis factor alpha and uses thereof" was invented by Hq Han (West... Read More